Literature DB >> 15036668

Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis.

Antonio Lopez-Beltran1, PierFrancesco Bassi, Michele Pavone-Macaluso, Rodolfo Montironi.   

Abstract

OBJECTIVE: Pathologists play a pivotal role in the diagnosis and in the report of the pathological features related to prognosis.
METHODS: To meet these endpoints, the following issues must be accomplished: adequate information about the patient history, proper handling of the specimens, identification of the reliable histopathological techniques necessary to reach the more detailed diagnostic information and evaluate the prognostic variables, and a standardized pathological report.
RESULTS: Recent efforts to standardize the histopathological evaluation have generated significant confusion among the urological and pathological communities as well. No consensus has been achieved about the optimal pathological grading of urothelial tumors, to date.
CONCLUSION: A proposal for standardization of sampling and reporting of the urothelial tissues achieved within Uropathology follows. The urologists have a great role in assisting pathologists in the proper examination by providing them with clinical information.

Entities:  

Mesh:

Year:  2004        PMID: 15036668     DOI: 10.1016/j.eururo.2003.09.018

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  16 in total

Review 1.  [Upper tract urothelial carcinoma. An update on clinical and pathological prognostic factors].

Authors:  M Rink; M Adam; J Hansen; F K Chun; S A Ahyai; M Remzi; T Schlomm; O Engel; R Heuer; C Eichelberg; M Fisch; R Dahlem; S F Shariat
Journal:  Urologe A       Date:  2012-09       Impact factor: 0.639

Review 2.  Prognostic factors for upper urinary tract urothelial carcinoma.

Authors:  Thomas F Chromecki; Karim Bensalah; Mesut Remzi; Grégory Verhoest; Eugene K Cha; Douglas S Scherr; Giacomo Novara; Pierre I Karakiewicz; Shahrokh F Shariat
Journal:  Nat Rev Urol       Date:  2011-07-05       Impact factor: 14.432

Review 3.  A practical guide to bladder cancer pathology.

Authors:  Eva Compérat; Justine Varinot; Julien Moroch; Caroline Eymerit-Morin; Fadi Brimo
Journal:  Nat Rev Urol       Date:  2018-01-31       Impact factor: 14.432

4.  Best practice in the treatment of nonmuscle invasive bladder cancer.

Authors:  Anastasios Anastasiadis; Theo M de Reijke
Journal:  Ther Adv Urol       Date:  2012-02

Review 5.  Predictive factors of recurrence and survival of upper tract urothelial carcinomas.

Authors:  Grégory Verhoest; Shahrokh F Shariat; Thomas F Chromecki; Jay D Raman; Vitaly Margulis; Giacomo Novara; Christian Seitz; Mesut Remzi; Morgan Rouprêt; Douglas S Scherr; Karim Bensalah
Journal:  World J Urol       Date:  2011-06-17       Impact factor: 4.226

6.  Differences in histopathological evaluation of standard lymph node dissections result in differences in nodal count but not in survival.

Authors:  L S Mertens; R P Meijer; E van Werkhoven; A Bex; H G van der Poel; B W van Rhijn; W Meinhardt; S Horenblas
Journal:  World J Urol       Date:  2012-08-09       Impact factor: 4.226

7.  Serum metabolomic analysis of human upper urinary tract urothelial carcinoma.

Authors:  Pengchao Li; Jun Tao; Dandan Wei; Xiao Yang; Zhaoguang Lu; Xiaheng Deng; Yiong Cheng; Jinbao Gu; Xuejian Yang; Zengjun Wang; Qiang Lu; Junsong Wang; Changjun Yin
Journal:  Tumour Biol       Date:  2015-04-28

Review 8.  Challenges in the pathology of non-muscle-invasive bladder cancer: a dialogue between the urologic surgeon and the pathologist.

Authors:  Donna E Hansel; Jeremy S Miller; Michael S Cookson; Sam S Chang
Journal:  Urology       Date:  2013-03-19       Impact factor: 2.649

9.  Full analysis of the prostatic urethra at the time of radical cystoprostatectomy for bladder cancer: impact on final disease stage.

Authors:  Justine Varinot; Philippe Camparo; Morgan Roupret; Marc Olivier Bitker; Fréderique Capron; Olivier Cussenot; J Alfred Witjes; Eva Compérat
Journal:  Virchows Arch       Date:  2009-10-20       Impact factor: 4.064

10.  Validation of the pretreatment derived neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.

Authors:  O Dalpiaz; M Pichler; S Mannweiler; J M Martín Hernández; T Stojakovic; K Pummer; R Zigeuner; G C Hutterer
Journal:  Br J Cancer       Date:  2014-04-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.